This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frehel, C. Articles by de Chastellier, C. Search for Related Content PubMed PubMed Citation Articles by Frehel, C. Articles by de Chastellier, C.

 Previous Article  |  Next Article 

Infect. Immun., 07 1997, 2792-2802, Vol 65, No. 7
Copyright © 1997, American Society for Microbiology

The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin

C Frehel, C Offredo and C de Chastellier
INSERM U411, Laboratoire de Microbiologie, UFR de Medecine Necker Enfants Malades, Paris, France.

Murine bone marrow-derived macrophages (Mphis) infected with virulent strains of Mycobacterium avium (TMC 724 and a human clinical isolate) or with an avirulent opaque variant that spontaneously dissociates from the virulent human clinical isolate were subjected to a prolonged and continuous treatment with clarithromycin added at the MIC. The efficiency of this antibiotic in terms of inhibition of bacterial growth and bacterial degradation was evaluated during a 21-day treatment period. Growth was assessed by determination of CFU of intracellular bacteria and by a quantitative ultrastructural analysis which allowed us also to determine the extent of bacterial degradation. A similar treatment was applied to the same strains growing in liquid medium. Our data show that in liquid medium, clarithromycin caused a 90% decrease in CFU within 7 days of treatment. When applied to Mphis infected with virulent M. avium, clarithromycin immediately arrested bacterial growth but was unable to fully kill and degrade intracellularly growing virulent bacteria. After 21 days of treatment, 25% of intracellular bacteria were still morphologically intact. These bacteria resumed growth upon removal of the antibiotic, with a normal replication rate. These bacteria had not become more resistant to the drug, since the MIC was unchanged as compared to the one determined for the initial stock used to infect Mphis. Our data therefore suggest that the intraphagosomal environment protects bacteria from degradation. We propose that the inability of the drug to completely destroy bacteria is the result of a limited accessibility of the drug due to prevention of fusions between the immature phagosomes in which virulent bacteria reside and lysosomes in which clarithromycin accumulates. In accord with our proposal, we show that the avirulent opaque variant, which does not prevent phagosome-lysosome fusions (unpublished data), is finally destroyed by clarithromycin even within the phagosomal environment.

This article has been cited by other articles:

• Greendyke, R., Byrd, T. F. (2008). Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria. Antimicrob. Agents Chemother. 52: 2019-2026 [Abstract] [Full Text]  
• Nguyen, H. A., Grellet, J., Paillard, D., Dubois, V., Quentin, C., Saux, M.-C. (2006). Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model. J Antimicrob Chemother 57: 883-890 [Abstract] [Full Text]  
• Bakker-Woudenberg, I. A. J. M., van Vianen, W., van Soolingen, D., Verbrugh, H. A., van Agtmael, M. A. (2005). Antimycobacterial Agents Differ with Respect to Their Bacteriostatic versus Bactericidal Activities in Relation to Time of Exposure, Mycobacterial Growth Phase, and Their Use in Combination. Antimicrob. Agents Chemother. 49: 2387-2398 [Abstract] [Full Text]  
• da Silva, T. R. M., de Freitas, J. R., Silva, Q. C., Figueira, C. P., Roxo, E., Leao, S. C., de Freitas, L. A. R., Veras, P. S. T. (2002). Virulent Mycobacterium fortuitum Restricts NO Production by a Gamma Interferon-Activated J774 Cell Line and Phagosome-Lysosome Fusion. Infect. Immun. 70: 5628-5634 [Abstract] [Full Text]  
• Hartmann, P., Becker, R., Franzen, C., Schell-Frederick, E., Römer, J., Jacobs, M., Fätkenheuer, G., Plum, G. (2001). Phagocytosis and killing of Mycobacterium avium complex by human neutrophils. J. Leukoc. Biol. 69: 397-404 [Abstract] [Full Text]  
• Guerin, I., de Chastellier, C. (2000). Pathogenic Mycobacteria Disrupt the Macrophage Actin Filament Network. Infect. Immun. 68: 2655-2662 [Abstract] [Full Text]  
• Birkness, K. A., Swords, W. E., Huang, P.-H., White, E. H., Dezzutti, C. S., Lal, R. B., Quinn, F. D. (1999). Observed Differences in Virulence-Associated Phenotypes between a Human Clinical Isolate and a Veterinary Isolate of Mycobacterium avium. Infect. Immun. 67: 4895-4901 [Abstract] [Full Text]  
• Sato, K., Tomioka, H. (1999). Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells. J Antimicrob Chemother 43: 351-357 [Abstract] [Full Text]  
• Via, L., Fratti, R., McFalone, M, Pagan-Ramos, E, Deretic, D, Deretic, V (1998). Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111: 897-905 [Abstract]